AACE

Registration and housing are open for the AACE Annual Meeting happening May 15-17, 2025, in Orlando, FL. Register now and save with early bird rates: aace.com/2025 #AACE2025 #endocrinology

Meet the 2026 travel award winners! INTERNATIONAL TRAVEL GRANT AWARDEE: Elena Castellano, MD Abstract: Estimated Fracture Risk Using the FRAX Score in Subjects With Asymptomatic Primary Hyperparathyroidism DOMESTIC TRAVEL GRANT AWARDEE: Justin Do, DO Abstract: Diabetic Ketoacidosis and Safety Outcomes With GLP-1 Agonists in Type 1 Diabetes DOMESTIC TRAVEL GRANT AWARDEE: Muhammad Sohaib Asghar, MD Abstract: Comparing Trends in Acute Myocardial Infarction-Related Mortality Among Type 2 Diabetic Versus Type 1 Diabetic Adults in the United States: Data From CDC WONDER 1999-2020

Even if your blood sugar is usually well managed, unexpected fluctuations can happen during illness, injury, or recovery, especially when your immune system is under stress. AACE Past President Scott D. Isaacs, MD, FACP, FACE, explains that during these times, your body temporarily prioritizes survival over perfect glucose control, even if you normally have very stable numbers. Read the Everyday Health article for practical strategies to help stabilize blood sugar: everydayhealth.com/diabetes/why-b…

These findings highlight the potential role of approved pharmacologic therapies for obesity, particularly liraglutide and naltrexone/bupropion, as treatment options for individuals with both obesity and binge eating, underscoring the need for standardized outcomes and further trials to guide clinical practice. Read more: endocrinepractice.org/article/S1530-… @vtangpricha

This study supports the safe use of metformin in transplant recipients living with diabetes, demonstrating an association with improved survival and cardiovascular outcomes and graft preservation. Read more: endocrinepractice.org/article/S1530-… @vtangpricha

These findings highlight the potential role of approved pharmacologic therapies for obesity, particularly liraglutide and naltrexone/bupropion, as treatment options for individuals with both obesity and binge eating, underscoring the need for standardized outcomes and further trials to guide clinical practice. Read more: endocrinepractice.org/article/S1530-… @vtangpricha

This meta-analysis offers evidence that dipeptidyl peptidase-4 inhibitor, glucagon-like peptide-1 receptor agonists, and sodium-glucose cotransporter-2 inhibitor are not associated with a higher risk of clinically detected bladder cancer, although the findings rely on passive reporting. Read more: endocrinepractice.org/article/S1530-… @vtangpricha

The new @TheAACE diabetes algorithm with its complications-centric approach to T2D care that prioritizes HF, CKD, ASCVD, stroke or TIA, and now #MASLD for the first time represents a major advance in clinical practice. I am proud that AACE is leading by formally integrating MASLD into diabetes treatment decisions. endocrinepractice.org/article/S1530-…

This review article aims to delineate the risks and benefits of TSH suppression in patients with differentiated thyroid cancer. Read more: endocrinepractice.org/article/S1530-… @vtangpricha

Today is the last day to register for #AACE26 at a discounted rate! Early bird pricing has ended, but discounted rates are still available through March 27. Join colleagues from across the endocrine community for evidence-based education, clinical updates, and opportunities to connect with leaders shaping the future of endocrine care. Secure your spot today: am.aace.com.

Prediabetes is more than glucose. It is a cardiometabolic warning sign tied to obesity, MASLD, dyslipidemia, hypertension, ASCVD, CKD and OSA. I am excited to discuss the new @TheAACE Prediabetes Algorithm at #ObesityMedicine2026 @OMAsocial #OM2026 endocrinepractice.org/article/S1530-…

Tomorrow is the last day to register for #AACE26 at a discounted rate! Early bird pricing has ended, but discounted rates are still available through March 27. Join colleagues from across the endocrine community for evidence-based education, clinical updates, and opportunities to connect with leaders shaping the future of endocrine care. Secure your spot today: am.aace.com.

Clinical endocrinology is evolving. Your learning should too. AACE Self-Assessment Program (ASAP) is being reimagined, not only as a board review tool, but as a next-generation learning portfolio designed for lifelong clinical excellence. Learn more: pro.aace.com/education-and-…

There's still time to register for #AACE26 at a discounted rate! Early bird pricing has ended, but discounted rates are still available through March 27. Join colleagues from across the endocrine community for evidence-based education, clinical updates, and opportunities to connect with leaders shaping the future of endocrine care. Secure your spot today: am.aace.com.

The 2026 @TheAACE type 2 diabetes algorithm marks a real shift toward complications-focused care. In my latest @MetabolicCare article, I break down what changed and how to use it in clinic. docwirenews.com/post/type-2-di…

The 2026 @TheAACE Diabetes Algorithm brings a new complications‑focused model for T2D care. @scottisaacsmd new article covers updates in prediabetes, ASCVD, CKD, HF & MASLD/MASH. Read his full breakdown: docwirenews.com/post/type-2-di… @MWeintraubMD @Neil_Iyengar @BevTchangMD

This study supports the safe use of metformin in transplant recipients living with diabetes, demonstrating an association with improved survival and cardiovascular outcomes and graft preservation. Read more: endocrinepractice.org/article/S1530-… @vtangpricha

As emails go, this is a good one! 📧 Incredibly honored to be named the recipient of the AACE Outstanding International Clinician Award. Thanks to my patients & peers who inspire me to be better every day. Thanks to the American Association of Clinical Endocrinology for the recognition 🏆

The XI International Course of Endocrinology, Diabetes and Metabolism – ENDIMET 2026, is coming to Cartagena, Colombia, April 23-26. Join colleagues from across the region for an outstanding program focused on the latest advances in endocrinology, diabetes, and metabolism. Learn more: congreso.endocrino.org.co

Our Health Care Advocacy Webinar Series is now available as a free, 4-part on-demand program designed for endocrinologists and health care professionals. Strengthen your voice in health care advocacy with expert-led insights on driving impact at the institutional, state, and national levels. This series explores emerging issues, including AI, team-based care, and telemedicine, and features live Q&A discussions with AACE experts. Learn more: pro.aace.com/advocacy/aace-….

Preview the AACE Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes – 2026 Update! This updated algorithm provides evidence-based visual guidance in graphic algorithms and a summary of evidence and considerations to assist healthcare professionals with the diagnosis and management of adults with prediabetes and type 2 diabetes in shared decision-making to improve care. View the preview: endocrinepractice.org/article/S1530-… #endocrinology